- Choosing when RWD can credibly support device regulatory questions
- Establishing data quality, provenance, and governance requirements
- Designing hybrid evidence packages combining trials and RWE
Archives: Agenda
Session reserved for event sponsor
Networking Lunch
Afternoon Networking & Refreshments
PANEL DISCUSSION Breaking the silos: how early clinical–regulatory–commercial alignment drives impact
- Identifying where misalignment between clinical, regulatory, and commercial teams most commonly breaks down and delays submissions or launches
- Understanding which decisions need cross-functional alignment from day one to ensure evidence supports both approval and adoption
- Sharing leadership-level lessons on how to structure collaboration early to avoid costly rework later in development
Moderator
Jodi Lamberti, VP, Clinical and Commercial Development, Visura Technologies